Glycostasis, Inc.

Glycostasis is developing a "smart" diabetes drug that can sense blood sugar levels and deliver insulin when and where it is needed.

Dr. John Mulligan, Ph.D.​

Founder and CEO

LinkedIn


Glucose-responsive insulin

Engineered insulin

Type I diabetes

Sensulin

Thermalin

Biocon